This cohort study of patients with stage III colon cancer enrolled in the CALGB 89803/Alliance trial evaluated the association of survival rates with adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors.
This population-based study analyzes cancer survivors’ ability to access and afford health care during implementation of the US Affordable Care Act using data from the 2010 to 2016 National Health Interview Survey.
This observational study examines associations of sarcopenia, muscle radiodensity, and adiposity with overall mortality in nonmetastatic breast cancer.
This genetic sequencing study explores whether up-front tumor sequencing can replace the prevailing paradigm for universal tumor screening for Lynch syndrome, which includes a sequence of several screening tests.
This nonrandomized, noncontrolled clinical trial evaluates the 6-month progression-free survival, tumor objective response, and overall survival rates in patients with gastrointestinal stromal tumors treated with dasatinib.
This case series assesses whether environmental exposures from the World Trade Center disaster site are associated with multiple myeloma and its precursor disease, monoclonal gammopathy of undetermined significance, in New York City firefighters.
This randomized clinical trial assesses whether dose-escalated radiation therapy vs standard dose improves survival for men with intermediate-risk prostate cancer.
This study compares preoperative chemoradiation followed by postoperative adjuvant chemotherapy vs total neoadjuvant therapy for treatment of locally advanced rectal cancer.
This cohort study projects the future burden of cancer among rescue and recovery workers exposed to multiple carcinogenic agents during the September 11, 2001, World Trade Center attack, by estimating the 20-year cancer incidence.
This analysis of data from the Surveillance, Epidemiology, and End Results program of cancer registries examines prevalence of prior cancer among individuals newly diagnosed with cancer.
This data analysis compares the analytical validity of US Food and Drug Administration–approved companion diagnostics and laboratory-developed tests for 3 genetic analytes using uniform reference materials from the College of American Pathologists Molecular Oncology Committee.
This analysis of health claims data from 3 large nationwide insurers examines changes in oral anticancer medication use, out-of-pocket spending, and total health plan spending associated with adoption of state parity laws.
This cohort study examines the reliability and potential utility of 2 commercially available liquid biopsy assays for reported mutations in cell-free DNA.
This multicenter randomized clinical trial compares oral ketamine with placebo for treating neuropathic pain in patients with cancer.
This study evaluates the use of a comprehensive screening protocol for prostate, breast, colorectal, and pancreatic cancer and skin malignant abnormalities in male BRCA carriers.
This study evaluates the duration of response for crizotinib vs chemotherapy for patients with ALK-positive lung cancer using data from the PROFILE-1014 randomized clinical trial.
This cross-sectional study describes the national distribution of genetic testing for hereditary cancer risk, identifies disparities, and assesses whether a gender gap exists
This randomized controlled crossover study compares patients’ perception of physicians’ compassion and patients’ perception of physicians’ communication skills and professionalism and patients’ overall physician preference after watching two standardized scripted-video vignettes of physicians.
This study compares conventional hazard ratios and an alternative, clinically interpretable approach to quantify the long-term survival benefit in patients receiving chemotherapy with immunotherapy.
This review describes all malignant hematology and oncology accelerated approvals from inception of the US Food and Drug Administration accelerated approval program.
This Insights discusses management strategies for metastatic melanoma using the most recent therapeutic options.
This synopsis summarizes the prospective randomized clinical trials that examined the use of rituximab maintenance therapy in treatment-naive patients with follicular lymphoma after first-line induction chemoimmunotherapy.
A 70-year-old Chinese man with a medical history of hypertension, hyperlipidaemia, and ischemic heart disease was referred to the urology clinic for 1 week of dysuria; there was a nonpruritic, erythematous, velvety plaque over the left base of his penis. What is your diagnosis?
This Viewpoint outlines an action plan to foster cooperation between cancer investigators in high-income countries and low- and middle-income countries.
This Viewpoint examines the evidence supporting the efficacy of intraoperative radiation therapy compared with other treatment modalities for patients with early-stage breast cancer.
This Viewpoint evaluates whether there is benefit for medical centers to advertise the opportunity for clinical trial participation.
This Patient Page explains tumor lysis syndrome, how it affects the body, who is at greatest risk, how to recognize it, and measures to help prevent it or treat it.
This article discusses a case in which music was used as a platform for initiating a conversation on end-of-life care.
Create a personal account or sign in to: